IN FOCUS: Solvias
Pharmaceutical Technology
DECEMBER 9, 2022
In regards to the latter, notable examples include the acquisition of Cergentis, a genomics-focused biotechnology company based in the Netherlands. The deal allows the company to provide proprietary technology and knowledge steeped in fast-evolving genomic techniques that support effective decision-making and R&D program design.
130 
Let's personalize your content